Amitiza Capsule, Gelatin Coated
Product Images NDC 23635-524

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amitiza (NDC 23635-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Amitiza 01)

Chemical Structure (Amitiza 01)
Chemical structure of lubiprostone, the active ingredient in Amitiza. The diagram shows the molecular arrangement with carbon, oxygen, hydrogen, and fluorine atoms clearly indicated by standard chemical notation.*
FDA Label Image

Principal Display Panel (8 mcg Capsule Bottle Label)

Principal Display Panel (8 mcg Capsule Bottle Label)
Amitiza 8 mcg (lubiprostone) gelatin-coated capsules label showing 60 capsules per container. The label includes directions to swallow whole without breaking or chewing, and indicates each soft gel capsule contains 8 mcg of lubiprostone. Marketed by Sucampo Pharma Americas LLC and SpecGx LLC, with packaging information and barcode also visible.*
FDA Label Image

Principal Display Panel (24 mcg Capsule Bottle Label)

Principal Display Panel (24 mcg Capsule Bottle Label)
Amitiza 24 mcg gelatin-coated capsules label showing 60 capsules per package. The label highlights the active ingredient lubiprostone with a strength of 24 mcg per capsule. The capsules are for oral use and marketed by Sucampo Pharma Americas LLC and SpecGx LLC. The label includes storage instructions and the NDC 23635-524-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.